Envisionit DeepAI

Cobham, England, United Kingdom  All United Kingdom companies → — Founded 2019
Imaging AI Specialist
Critical Care Emergency Medicine Radiology
Radiology & Imaging AI Triage & ER/ICU AI
Seed
Claim this company

Products

Radify Triage
Envisionit Deep AI
Radiology & Imaging AI
Radify Triage by Envisionit DeepAI is an FDA-cleared AI tool for rapid, accurate triage and prioritization of adult chest X-ray images, specifically detecting pneumothorax and pleural effusion.

See all 1 product →

About Envisionit DeepAI

Envisionit DeepAI is an innovative medical technology company that leverages Artificial Intelligence (AI) to transform medical imaging diagnosis. The company’s core mission is to empower radiologists with trusted AI solutions that are validated, transparent, and continuously monitored, ultimately aiming to democratize access to diagnostic healthcare.

Their flagship product, RADIFY (now referred to as RATIFY for AI Assurance), is an AI assurance platform designed to support the safe and effective use of AI in radiology workflows. It acts as an independent, vendor-agnostic platform that provides real-time validation, tracks human-AI interaction, and detects drift in AI performance. This is particularly crucial in addressing the challenges of real-world AI validation and monitoring, ensuring that AI tools perform reliably once deployed in clinical settings. Envisionit DeepAI’s solutions are developed to assist radiologists in diagnosing more images, more consistently, and in less time, while also prioritizing urgent cases. They aim to reduce diagnostic errors and improve the efficiency and consistency of medical imaging interpretation across various modalities, including X-rays and mammography.

Focus Areas

medical imaging AI diagnostic radiology radiology workflow chest X-ray AI triage AI computer vision clinical decision support explainable AI AI validation AI monitoring

Business Intelligence

Technologycloud-native, machine learning algorithms, explainable AI

What Physicians Need to Know

Medical Imaging AI & Diagnostic Radiology
Envisionit DeepAI specializes in AI-powered diagnostic tools for medical imaging, including X-rays, ultrasound, MRI, and CT scans. Their flagship product, RADIFY®, assists radiologists in diagnosing various diseases by detecting and highlighting abnormalities. RADIFY® for Chest, for example, can detect 20 major abnormalities on chest X-rays and triage urgent cases, labeling and prioritizing over 2000 X-rays per minute. They also have RADIFY® for mammograms to aid in breast cancer screening and diagnosis. RADIFY® AI has received FDA 510(k) clearance for triaging pneumothorax and pleural effusion, demonstrating high accuracy and speed.
Radiology Workflow & Triage AI
The company's solutions are designed to streamline and improve radiology workflows. RADIFY® acts as a clinical decision support tool, enabling radiologists to diagnose more images, more consistently, in less time, and at a lower cost. Its triage capabilities prioritize urgent or life-threatening cases, ensuring that patients who need immediate attention are identified quickly, even in high-volume settings.
Computer Vision & Explainable AI
Envisionit DeepAI leverages machine learning and computer vision to recognize patterns in medical images and annotate them. A core aspect of their offerings is explainable AI, which aims to provide transparency and insights into how AI models arrive at their diagnostic recommendations, fostering trust among healthcare providers.
AI Validation & Monitoring (RATIFY®)
A key specialization is their independent, vendor-agnostic AI assurance platform, RATIFY®. RATIFY® addresses the critical need for real-world AI validation and continuous monitoring of AI tools in healthcare. It provides real-time validation, human-AI interaction tracking, drift detection, bias detection, and performance benchmarking, ensuring AI safety, explainability, and regulatory compliance (e.g., EU AI Act, FDA guidance).
Clinical Decision Support
Envisionit DeepAI's AI solutions serve as clinical decision support tools, assisting doctors in making faster and more accurate diagnoses by providing analyzed images and recommendations.
Physician Tip

Envisionit DeepAI's solutions, particularly RADIFY® and RATIFY®, are designed to empower physicians by providing trusted, transparent, and continuously monitored AI. RADIFY® can significantly enhance diagnostic speed and accuracy, especially for high-volume screenings like chest X-rays and mammograms, by detecting and prioritizing critical abnormalities. This allows for more efficient patient care and resource allocation. RATIFY® offers crucial assurance by validating and monitoring AI tools in real-world settings, addressing concerns about AI performance, bias, and regulatory compliance. This platform provides auditable evidence of AI performance, strengthening clinician confidence and reducing medico-legal risks. The explainable AI aspect ensures that physicians can understand the AI's reasoning, fostering greater trust and facilitating adoption into clinical practice.

RATIFY® is designed for seamless integration into existing PACS/RIS workflows and AI platforms through secure APIs, operating autonomously in the background without disrupting current clinical processes. This vendor-agnostic approach allows for the monitoring of third-party AI medical imaging solutions.

Products by Envisionit DeepAI

1 product in the directory

Radify Triage
Envisionit Deep AI
Radiology & Imaging AI
Radify Triage by Envisionit DeepAI is an FDA-cleared AI tool for rapid, accurate triage and prioritization of adult chest X-ray images, specifically detecting pneumothorax and pleural effusion.

What the Web Says

Envisionit DeepAI is a healthcare technology company focused on an AI assurance platform for radiology called RATIFY. While specific reviews for "Envisionit DeepAI" are limited on major review sites, there are some insights into a company called "Envisionit" (likely a related entity or a broader agency) and a separate product called "DeepAI" (an AI image and video generation tool). The available information suggests a mixed sentiment, with some positive feedback on teamwork and product concept, but also concerns about product quality and clarity of pricing.

Overall: Mixed

Strengths

  • Strong sense of teamwork and collaboration (for Envisionit as an employer).
  • Great for architectural elements, designs, and furnishings (DeepAI product).
  • Many great styles of image generation (DeepAI product).
  • Good quality for specific image generation styles like cyberpunk (DeepAI product).
  • Concept of AI-generated images and videos is great (DeepAI product).
  • Helps incline solutions to be more customer-centric (Artificial Intelligence Technology Solutions, a related AI company on G2).

Limitations

  • Challenging environment with room for improvement in leadership and support (for Envisionit as an employer).
  • Quality of AI-generated output is often useless (DeepAI product).
  • AI brain seems 'off' from prompts (DeepAI product).
  • Subscription and pay-as-you-go model can add up, desire for one-time purchase option (DeepAI product).
  • Lack of clarity on the number of free tries (DeepAI product).
  • Website user experience is terrible (DeepAI product, older Reddit review).

Based on reviews from: Indeed.com, Capterra, Reddit, Parse.gl, FDA.gov, Healthcare IT News, G2

Last updated: 2026-10-24

Videos

News, demos, and interviews about Envisionit DeepAI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Envisionit DeepAI →

View all on YouTube

Press & Coverage

MAGNiTT
Envisionit Deep AI raises $1.65M
South African healthtech startup Envisionit Deep AI raised $1.65 million in funding from New GX Ventures SA to expand access to medical imaging and further develop its AI platform, Radify AI. The company aims to address critical shortages in the African healthcare sector.
2023-02
Data Phoenix
Envisionit Deep AI raises $1.65 million to expand access to medical imaging
Envisionit Deep AI secured $1.65 million in funding to expand its AI-powered medical imaging diagnosis technology to more healthcare facilities, particularly in rural areas, and to support other medical specialties beyond radiology. The company was founded in 2019 by doctors and computer scientists to address the shortage of radiologists in South Africa.
2023-03
FirstWord HealthTech
Envisionit Deep AI Raises $1.65 Million, Infusing AI with Radiology
Envisionit Deep AI raised $1.65 million to scale its AI solutions, including the Radify AI platform, which aims to make medical imaging diagnosis faster, more accurate, and affordable. The company is seeking approval from the FDA and European Medical Agency for its products.
2023-02
AuntMinnie
Envisionit receives FDA clearance for Radify system
Envisionit Deep AI received 510(k) clearance from the FDA for its AI-assisted chest X-ray system, Radify, for triaging pneumothorax and pleural effusion. The system demonstrated high accuracy and speed in alerting healthcare professionals.
2024-01
AI Device Index
Radify Triage by Envisionit DeepAI Ltd · FDA AI device (K231871)
Radify Triage by Envisionit DeepAI Ltd was cleared by the FDA on January 17, 2024, through the 510(k) pathway, classified as a Class II Radiological Computer-Assisted Prioritization Software for Lesions. This makes it an FDA-authorized AI-enabled medical device.
2024-01
Hardian Health
How to gain FDA clearance for AI
Envisionit Deep AI became the first African-founded company to receive FDA clearance for an AI device, with Hardian Health's support for their RADIFY® AI solution. This clearance is for triaging pneumothorax and pleural effusion, addressing critical needs in emergency and intensive care.
2024-03
Daba Finance
South Africa's Envisionit Deep AI Partners with Pharma Giant Bayer
Envisionit Deep AI has partnered with pharmaceutical giant Bayer to explore applications of its radiology-focused AI tools, investigating future use cases with Bayer's AI Innovation Platform. This collaboration follows Envisionit Deep AI's $1.65 million funding round in February 2023.
2024-12
Envisionit Deep AI
Innovating Radiology with AI: Bayer's New Collaborations at RSNA 2024
Envisionit Deep AI announced new collaborations with Bayer at RSNA 2024, focusing on pushing the boundaries of AI-enabled applications for radiology to advance healthcare and ensure better outcomes for patients and physicians.
2025-01

Frequently Asked Questions

Envisionit DeepAI offers RADIFY, an AI platform designed to streamline and enhance medical imaging diagnosis for radiologists. RADIFY for Chest, for example, detects 20 major abnormalities on chest X-rays, labels and prioritizes over 2000 X-rays per minute, and can triage urgent cases like pneumothorax and pleural effusion. This significantly improves radiology workflow by enabling faster, more consistent diagnoses and prioritizing critical cases.
Envisionit DeepAI addresses these concerns with its RATIFY platform, an independent, vendor-agnostic AI assurance platform. RATIFY provides real-time validation, human-AI interaction tracking, and drift detection, ensuring continuous monitoring of AI tool performance post-deployment. It also focuses on explainable AI solutions to build trust and provides auditable proof of algorithm performance, aligning with ethical AI principles and regulatory standards.
Envisionit DeepAI's RADIFY AI has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for triaging pneumothorax and pleural effusion. The company is also ISO 13485 certified, which is an international standard for medical device quality management systems. Furthermore, their RATIFY platform is designed to support compliance with the EU AI Act and updated FDA guidance, and the company is committed to GDPR and POPIA compliance for data privacy.
Envisionit DeepAI actively seeks partnerships with hospitals, radiology practices, and occupational health providers. They have notably collaborated with Bayer in the radiology domain to explore future use cases for AI-driven medical imaging diagnostics. The company has raised $1.65 million in seed funding from investors like New GX Ventures SA and Founders Factory Africa, indicating financial backing and a focus on expansion.
While RADIFY for Chest is a primary product, Envisionit DeepAI has also developed tools for mammography and dermatology (Dermify). Their RATIFY platform is designed to be versatile and applicable beyond radiology, supporting AI assurance and monitoring across various diagnostic domains including pathology, cardiology, and ophthalmology.

Related Companies

A2
A2z Radiology Ai
Boston, MA, USA

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Pe
Perimeter Medical Imaging AI
Toronto, Canada and Dallas, Texas, USA

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS
Rolle, Switzerland and Boston, Massachusetts, United States

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai
Mumbai, India

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
DeepBio
Seoul, South Korea

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare
Dallas, TX, United States

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.